What is the appropriate N‑acetylcysteine (NAC) dosing regimen to start in a patient with suspected rat rodenticide poisoning?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

N-Acetylcysteine for Rat Poisoning: Start Immediately with Standard IV Protocol

Begin intravenous N-acetylcysteine at 300 mg/kg total dose over 12-20 hours immediately upon presentation of suspected rat poisoning, without waiting for confirmatory tests. The evidence strongly supports NAC's survival benefit in rodenticide poisoning, particularly when initiated early 1, 2.

Dosing Regimen

Use one of these evidence-based protocols:

Preferred: 12-Hour SNAP Protocol

  • Loading dose: 150 mg/kg IV over 1 hour
  • Maintenance: 150 mg/kg IV over the next 11 hours
  • Total dose: 300 mg/kg over 12 hours 3

This simplified regimen reduces adverse effects and shortens hospital stays compared to traditional protocols 3.

Alternative: Traditional 20-21 Hour Protocol

  • Loading dose: 150 mg/kg IV over 1 hour
  • Second infusion: 50 mg/kg IV over 4 hours
  • Third infusion: 100 mg/kg IV over 16 hours
  • Total dose: 300 mg/kg over 21 hours 4

Clinical Evidence Supporting NAC in Rodenticide Poisoning

The rationale differs from acetaminophen overdose but the mechanism is similar—NAC acts as an antioxidant and glutathione precursor to combat oxidative stress from phosphine gas (in zinc phosphide rodenticides) or other hepatotoxic compounds 1, 5.

Key findings:

  • Meta-analysis of RCTs showed significant recovery (OR 3.97) and reduced mortality (OR 0.25) with NAC treatment 1
  • Retrospective data from 229 patients demonstrated significantly higher survival rates in NAC-treated groups 2
  • Patients receiving NAC had lower peak AST/ALT levels and shorter hospital stays 5

Critical Timing Considerations

Start NAC immediately—do not delay for:

  • Confirmatory testing of rodenticide type
  • Baseline liver function tests
  • Patient history clarification

Time-dependent mortality risk factors:

  • Time lag ≥24 hours increases mortality risk 3.5-fold 2
  • Yellow phosphorus poisoning carries 2.9-fold higher mortality risk 2

Monitoring and Extension Criteria

Continue NAC beyond initial protocol if:

  • AST/ALT remain elevated or rising
  • INR remains abnormal
  • Patient develops signs of hepatotoxicity or organ dysfunction
  • Clinical deterioration occurs

Safe stopping criteria (after completing initial protocol):

  • Liver enzymes stable or falling
  • INR acceptable
  • No clinical signs of hepatotoxicity
  • Patient clinically improving 6

Practical Implementation

Loading dose calculation example:

  • 70 kg patient: 150 mg/kg = 10,500 mg
  • Using 20% NAC solution: 52.5 mL diluted in 200 mL D5W or normal saline
  • Infuse over 1 hour

Common pitfall: Do not withhold NAC because the specific rodenticide is unknown. Most rodenticides in India contain hepatotoxic agents (yellow phosphorus, zinc phosphide), and NAC has demonstrated benefit across rodenticide types 1, 2, 5.

Safety Profile

NAC is remarkably safe in this context:

  • 93.4% of patients experience no adverse effects 2
  • Non-IgE-mediated reactions (flushing, nausea) are less common with slower infusion rates
  • SNAP protocol reduces adverse events compared to traditional dosing 3

Additional Supportive Care

While administering NAC:

  • Gastric decontamination if presenting within 1-2 hours
  • Aggressive fluid resuscitation
  • Monitor for metabolic acidosis (especially zinc phosphide)
  • Serial liver function tests, INR, creatinine
  • Early ICU consultation for severe cases
  • Consider early hepatology/transplant referral if fulminant hepatic failure develops

The evidence is clear: NAC improves survival in rodenticide poisoning when started early, uses the same dosing as acetaminophen overdose, and has minimal risk 1, 2, 5. The 12-hour SNAP protocol offers practical advantages with equivalent efficacy 3.

Related Questions

How is intravenous N‑acetylcysteine (NAC) prepared for the two‑bag (20‑hour) regimen?
What is the recommended intravenous N‑acetylcysteine (NAC) regimen for a 50‑kg patient with paracetamol (acetaminophen) poisoning?
Can N‑acetylcysteine infusion be administered in a patient with unknown rat‑killer poisoning who has normal liver function tests?
At what dose of paracetamol (acetaminophen) poisoning should N‑acetylcysteine be started?
How to dilute N-acetylcysteine (NAC) in a patient with myocarditis secondary to rodenticide consumption, elevated Central Venous Pressure (CVP) indicating potential fluid overload, and risk of heart failure?
What are the sonographic features of acute kidney injury (AKI) on renal ultrasound?
In a patient with acute liver failure due to suspected poisoning, should plasmapheresis be initiated as a bridge to liver transplantation?
What is the clinical significance of urine potassium measurement in the evaluation of hypokalemia?
What is the most likely diagnosis and recommended treatment for a 19-year-old female with recent pneumonia presenting with lower‑lip vesicles and multiple oral ulcers?
In a patient with symptomatic hypokalemia (serum potassium 2.87 mmol/L) who only has 600 mg (≈8 mEq) potassium chloride tablets available, how should the potassium be dosed when the IV fluid is changed to 0.9% sodium chloride, with an initial 100 mL rapid infusion followed by a maintenance rate of 80 mL per hour?
Can cardiac troponin be elevated in pulmonary embolism, and what is the underlying mechanism?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.